Report and Recommendations of the Workshop of the European Centre for the Validation of Alternative Methods for Drug-Induced Cardiotoxicity

• Published in: Cardiovascular toxicology Vol. 9; no. 3; pp. 107 - 125
• Main Authors: Stummann, Tina C, Beilmann, Mario, Duker, Göran, Dumotier, Berengere, Fredriksson, J. Magnus, Jones, Robin L, Hasiwa, Marina, Kang, Y. James, Mandenius, Carl-Fredrik, Meyer, Thomas, Minotti, Giorgio, Valentin, Y. Jean-Pierre, Zünkler, Bernd J, Bremer, Susanne
• Format: Journal Article
• Language: English
• Published: New York New York : Humana Press Inc 01.09.2009; Humana Press Inc; Springer Nature B.V
• Subjects: Alternative tests; Animal Testing Alternatives - methods; Animal Testing Alternatives - trends; Animals; Animals, Laboratory; Arrhythmias; Arrhythmias, Cardiac - chemically induced; Arrhythmias, Cardiac - prevention & control; Biomedical and Life Sciences; Biomedicine; Cardiology; Cardiotoxicity; Cardiotoxins - adverse effects; Cardiotoxins - toxicity; Clinical trials; Contractility toxicity; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions - chemically induced; Drug-Related Side Effects and Adverse Reactions - prevention & control; Drugs; Education - trends; Europe; Health Planning Guidelines; Humans; Ischaemia toxicity; MEDICIN; MEDICINE; Pharmacology/Toxicology; Secondary cardiotoxicity; Valve toxicity; Europe; Drugs; Valve toxicity; Secondary cardiotoxicity; Cardiotoxicity; Ischaemia toxicity; Alternative tests; Arrhythmias; Contractility toxicity
• ISSN: 1530-7905; 1559-0259; 1559-0259
• DOI: 10.1007/s12012-009-9045-3

Cardiotoxicity is among the leading reasons for drug attrition and is therefore a core subject in non-clinical and clinical safety testing of new drugs. European Centre for the Validation of Alternative Methods held in March 2008 a workshop on “Alternative Methods for Drug-induced Cardiotoxicity” in order to promote acceptance of alternative methods reducing, refining or replacing the use of laboratory animals in this field. This review reports the outcome of the workshop. The participants identified the major clinical manifestations, which are sensitive to conventional drugs, to be arrhythmias, contractility toxicity, ischaemia toxicity, secondary cardiotoxicity and valve toxicity. They gave an overview of the current use of alternative tests in cardiac safety assessments. Moreover, they elaborated on new cardiotoxicological endpoints for which alternative tests can have an impact and provided recommendations on how to cover them.